Y0001498

Lopinavir

European Pharmacopoeia (EP) Reference Standard

• 実験式（ヒル表記法）: C₃₇H₄₈N₄O₅
• CAS番号: 192725-17-0
• 分子量: 628.80
• UNSPSCコード: 41116107
• NACRES: NA.24

特性

• 由来生物: synthetic
• グレード: pharmaceutical primary standard
• 認証: EP
• APIファミリー: lopinavir
• 包装: pkg of 170 mg
• メーカー／製品名: EDQM
• 保管条件: protect from light
• アプリケーション: pharmaceutical (small molecule)
• フォーマット: neat
• 輸送温度: ambient
• 保管温度: 2-8°C
• SMILES記法: N4(CCCNC4=O)[C@@H](C(C)C)C(=O)N[C@H](C[C@H](O)[C@@H](NC(=O)COc3c(cccc3C)C)Cc2ccccc2)Cc1ccccc1
• InChI: 1S/C37H48N4O5/c1-25(2)34(41-20-12-19-38-37(41)45)36(44)39-30(21-28-15-7-5-8-16-28)23-32(42)31(22-29-17-9-6-10-18-29)40-33(43)24-46-35-26(3)13-11-14-27(35)4/h5-11,13-18,25,30-32,34,42H,12,19-24H2,1-4H3,(H,38,45)(H,39,44)(H,40,43)/t30-,31-,32-,34-/m0/s1
• InChI Key: KJHKTHWMRKYKJE-SUGCFTRWSA-N

詳細

詳細

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.

Lopinavir is an antiretroviral agent and a protease inhibitor indicated for the management of human immunodeficiency virus (HIV) infection. It is a key component of Kaletra, the co-formulation of lopinavir and ritonavir.

アプリケーション

Lopinavir may be used as a EP reference standard for the determination of the analyte in pharmaceutical formulations and plasma samples by chromatography techniques.

包装

The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.

その他情報

Sales restrictions may apply.

安全性情報

• 保管分類コード: 11 - Combustible Solids
• WGK: WGK 3
• 引火点(°F): Not applicable
• 引火点(℃): Not applicable